Healthcare provider profile · identity verified

Patrick Joseph Boyce, M.D.

Internal Medicine · SOUTH HADLEY, MA · NPI 1336194984

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	600	170
Lisinopril	Lisinopril	559	155
Amlodipine Besylate	Amlodipine Besylate	438	126
Omeprazole	Omeprazole	339	95
Losartan Potassium	Losartan Potassium	288	77
Hydrochlorothiazide	Hydrochlorothiazide	254	75
Gabapentin	Gabapentin	243	66
Levothyroxine Sodium	Levothyroxine Sodium	237	66
Metoprolol Succinate	Metoprolol Succinate	212	61
Oxycodone Hcl	Oxycodone Hcl	206	35
Simvastatin	Simvastatin	197	58
Lorazepam	Lorazepam	173	55
Metformin Hcl Er	Metformin Hcl	171	48
Pantoprazole Sodium	Pantoprazole Sodium	171	42
Eliquis	Apixaban	157	30
Rosuvastatin Calcium	Rosuvastatin Calcium	146	45
Albuterol Sulfate Hfa	Albuterol Sulfate	131	43
Atenolol	Atenolol	125	35
Furosemide	Furosemide	112	44
Sertraline Hcl	Sertraline Hcl	108	33
Valsartan	Valsartan	93	26
Tamsulosin Hcl	Tamsulosin Hcl	90	29
Ibuprofen	Ibuprofen	86	19
Metoprolol Tartrate	Metoprolol Tartrate	85	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	81	14
Fluticasone Propionate	Fluticasone Propionate	79	38
Bupropion Xl	Bupropion Hcl	77	22
Carvedilol	Carvedilol	73	21
Pravastatin Sodium	Pravastatin Sodium	72	22
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	67	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	65	15
Allopurinol	Allopurinol	64	20
Metformin Hcl	Metformin Hcl	64	23
Synthroid	Levothyroxine Sodium	64	20
Hydralazine Hcl	Hydralazine Hcl	63	17
Fluoxetine Hcl	Fluoxetine Hcl	61	15
Celecoxib	Celecoxib	57	15
Tramadol Hcl	Tramadol Hcl	57	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	19
Prednisone	Prednisone	56	29
Olmesartan Medoxomil	Olmesartan Medoxomil	53	14
Nifedipine Er	Nifedipine	52	11
Escitalopram Oxalate	Escitalopram Oxalate	51	18
Irbesartan	Irbesartan	51	16
Citalopram Hbr	Citalopram Hydrobromide	47	17
Glipizide Er	Glipizide	46	11
Warfarin Sodium	Warfarin Sodium	44	11
Trazodone Hcl	Trazodone Hcl	43	15
Januvia	Sitagliptin Phosphate	41	suppressed
Famotidine	Famotidine	38	14
Finasteride	Finasteride	38	12
Alprazolam	Alprazolam	37	suppressed
Clonazepam	Clonazepam	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Meloxicam	Meloxicam	36	11
Trulicity	Dulaglutide	35	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Spironolactone	Spironolactone	33	11
Valacyclovir	Valacyclovir Hcl	33	15
Buspirone Hcl	Buspirone Hcl	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Ketoconazole	Ketoconazole	31	21
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Mirtazapine	Mirtazapine	29	11
Ondansetron Odt	Ondansetron	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Potassium Chloride	Potassium Chloride	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Fentanyl	Fentanyl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Azithromycin	Azithromycin	25	21
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Cefuroxime	Cefuroxime Axetil	23	16
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	14
Ezetimibe	Ezetimibe	20	suppressed
Ozempic	Semaglutide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Diazepam	Diazepam	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Amoxicillin	Amoxicillin	18	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Naproxen	Naproxen	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Glipizide	Glipizide	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nyamyc	Nystatin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Torsemide	Torsemide	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Famciclovir	Famciclovir	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nadolol	Nadolol	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error